Allosteric Bioscience
New York, US · Founded 2021 · Delaware corporation
Find your way into Allosteric Bioscience
Sign up to see every warm intro you have to Allosteric Bioscience
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Allosteric Bioscience team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
BM
Bruce MeyersNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$920K disclosed across 1 round · 2021
▶$920KraisedDec 2021 · 14 investors · PharmaceuticalsRule 506(b)
▶$920KraisedDec 2021 · 14 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Bruce MeyersExecutive Officer, Director, Promoter
- Offering amount
- $3M
- Amount sold
- $920K
- Minimum investment
- $5K
- First sale
- Dec 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Allosteric Bioscience raised?
- Allosteric Bioscience has disclosed $920K raised across 1 round.
- Where is Allosteric Bioscience headquartered?
- Allosteric Bioscience is headquartered in New York, US.